$89.9 Million is the total value of Bill & Melinda Gates Foundation's 8 reported holdings in Q4 2023. The portfolio turnover from Q3 2023 to Q4 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMRS | Exit | AMYRIS INC | $0 | – | -292,398 | -100.0% | -0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CUREVAC N V | 15 | Q2 2024 | 58.0% |
| VIR BIOTECHNOLOGY INC | 15 | Q2 2024 | 32.0% |
| BIONTECH SE | 15 | Q2 2024 | 35.8% |
| IMMUNOCORE HLDGS PLC | 14 | Q2 2024 | 44.6% |
| BUTTERFLY NETWORK INC | 14 | Q2 2024 | 3.8% |
| ATRECA INC | 14 | Q1 2024 | 5.3% |
| AMYRIS INC | 12 | Q3 2023 | 1.2% |
| EXSCIENTIA | 11 | Q2 2024 | 13.6% |
| LUMIRADX LTD | 10 | Q1 2024 | 18.0% |
| ZYMERGEN INC | 6 | Q3 2022 | 0.3% |
View Bill & Melinda Gates Foundation's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LumiraDx Ltd | August 03, 2022 | 19,859,773 | 15.8% |
| Atreca, Inc. | February 16, 2021 | 1,396,644 | 4.7% |
| Liquidia Technologies Inc | February 12, 2020 | 119,678 | 0.5% |
| X4 Pharmaceuticals, Inc | March 15, 2019 | 120,363 | 1.8% |
| Arsanis, Inc. | February 13, 2018 | 722,179 | 5.1% |
View Bill & Melinda Gates Foundation's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-09-03 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
View Bill & Melinda Gates Foundation's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.